Antimicrobial susceptibility and molecular epidemiology of Streptococcus pneumoniae isolated from Shanghai, China

International Journal of Antimicrobial Agents

Volumn 32, Issue 5, 2008, Pages 386-391

  Yang, Fan ^a   Xu, Xiao Gang ^a   Yang, Min Jie ^a   Zhang, Ying Yuan ^a   Klugman, Keith P ^b   McGee, Lesley ^b  

^a FUDAN UNIVERSITY   (China)

^b EMORY UNIVERSITY   (United States)

Author keywords

Antibiotics; Pneumococci; Resistance; Serotyping

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; PENICILLIN G; TETRACYCLINE;

ADULT; ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CHINA; CONTROLLED STUDY; ERM GENE; GENE IDENTIFICATION; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; MEF GENE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PEDIATRICS; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHINA; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; ERYTHROMYCIN; HUMANS; MACROLIDES; PENICILLIN RESISTANCE; PENICILLIN-BINDING PROTEINS; PNEUMOCOCCAL INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TAIWAN;

EID: 53249103155     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.05.004     Document Type: Article

References (40)

1. Musher D.M. Streptococcus pneumoniae. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Principals and practice of infectious diseases. 6th ed. (2005), Churchill Livingstone, Philadelphia, PA
2. Davies T., Goering R.V., Lovgren M., Talbot J.A., Jacob M.R., and Appelbaum P.C. Molecular epidemiological survey of penicillin-resistant Streptococcus pneumoniae from Asia, Europe, and North America. Diagn Microbiol Infect Dis 34 (1999) 7-12
3. Farrell D.J., Jenkins S.G., Brown S.D., Patel M., Lavin B.S., and Klugman K.P. Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance. Emerg Infect Dis 11 (2005) 851-858
4. McGee L., McDougal L., Zhou J., Spratt B.G., Tenover F.C., Geroge R., et al. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the Pneumococcal Molecular Epidemiology Network. J Clin Microbiol 39 (2001) 2565-2571
5. Pletz M.W., McGee L., Jorgensen J., Beall B., Facklam R.R., Whitney C.G., et al. Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine. Antimicrob Agents Chemother 48 (2004) 3491-3497
6. Reinert R.R., Ringelstein A., van der Linden M., Cil M.Y., AI-Lahham A., and Schmitz F.J. Molecular epidemiology of macrolide-resistant Streptococcus pneumoniae isolates in Europe. J Clin Microbiol 43 (2005) 1294-1300
7. Richter S.S., Heilmann K.P., Beekmann S.E., Mill N.J., Rice C.L., and Doern G.V. The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations. Clin Infect Dis 40 (2005) 225-235
8. Ip M., Chau S.S.L., Chi F., Cheuk S.C., Ma H., and Chan P.K. Longitudinally tracking fluoroquinolone resistance and its determinants in penicillin-susceptible and -nonsusceptible Streptococcus pneumoniae isolates in Hong Kong. Antimicrob Agents Chemother 51 (2007) 2192-2194
9. Kasahara K., Maeda K., Mikasa K., Uno K., Takahashi K., Konishi M., et al. Clonal dissemination of macrolide-resistant and penicillin-susceptible serotype 3 and penicillin-resistant Taiwan 19F-14 and 23F-15 Streptococcus pneumoniae isolates in Japan: a pilot surveillance study. J Clin Microbiol 43 (2005) 1640-1645
10. Shi Z.Y., Enright M.C., Wilkinson P., Griffiths D., and Spratt B.G. Identification of three major clones of multiply antibiotic-resistant Streptococcus pneumoniae in Taiwanese hospitals by multilocus sequence typing. J Clin Microbiol 36 (1998) 3514-3519
11. Song J.H., Chang H.H., Suh J.Y., Ko K.S., Jung S.I., Oh W.S., et al. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP). J Antimicrob Chemother 53 (2004) 457-463
12. Song J.H., Jung S.I., Ko K.S., Kim N.Y., Son J.S., Chang H.H., et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP Study). Antimicrob Agents Chemother 48 (2004) 2101-2107
13. Song J.H., Lee N.Y., Ichiyama S., Yoshida R., Wang F., Chongthaleong A., et al. Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin Infect Dis 28 (1999) 1206-1211
14. Wang H., Huebner R., Chen M., and Klugman K.P. Antibiotic susceptibility patterns of Streptococcus pneumoniae in China and comparison of MICs by agar dilution and E-test methods. Antimicrob Agents Chemother 42 (1998) 2633-2636
15. Yang F., Zhang Y.Y., and McGee L. Population biology of Streptococcus pneumoniae carried by healthy children in Shanghai. Zhonghua Yi Xue Za Zhi 81 (2001) 589-592 [in Chinese]
16. Wang H., Yu Y.S., Liu Y., Li H.Y., Hu B.J., Sun Z.Y., et al. Resistance surveillance of common community respiratory pathogens isolated in China, 2002-2003. Zhonghua Jie He He Hu Xi Za Zhi 27 (2004) 155-160 [in Chinese]
17. Zhao T.M., Fang X.Q., and Liu Y. Resistance phenotypes and genotypes of erythromycin-resistant Streptococcus pneumoniae isolates in Beijing and Shenyang, China. Antimicrob Agents Chemother 48 (2004) 4040-4041
18. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 7th ed. Approved standard. M7-A7. Wayne, PA: CLSI; 2006.
19. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Sixteenth informational Supplement. M100-S16. Wayne, PA: CLSI; 2006.
20. Pai R., Gertz R.E., and Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol 44 (2006) 124-131
21. Enright M., and Spratt B.G. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144 (1998) 3049-3060
22. Gertz Jr. R.E., McEllistrem M.C., Boxrud D.J., Boxrud D.J., Li Z., Sakota V., et al. Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J Clin Microbiol 41 (2003) 4194-4216
23. Feil E.J., Li B.C., Aanensen D.M., Hanage W.P., and Spratt B.G. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol 186 (2004) 1518-1530
24. Gherardi G., Whitney C.G., Facklam R.R., and Beall B. Major related sets of antibiotic-resistant pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. J Infect Dis 181 (2000) 216-229
25. Sutcliffe J., Grebe T., Tait-Kamradt A., and Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 40 (1996) 2562-2566
26. Widdowson C., and Klugman K.P. Emergence of the M-phenotype of erythromycin-resistant pneumococci in South Africa. Emerg Infect Dis 4 (1998) 277-281
27. Montanari M.P., Mingoia M., Cochetti I., and Varaldo P.E. Phenotypes and genotypes of erythromycin-resistant pneumococci in Italy. J Clin Microbiol 41 (2003) 428-431
28. Chen D.K., McGeer A., de Azavedo J.C., and Low D.F. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med 341 (1999) 233-239
29. Doern G.V., Brueggemann A., Holley Jr. H.P., and Rauch A.M. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 40 (1996) 1208-1213
30. Morrissey I., Colclough A., and Northwood J. TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents. Int J Antimicrob Agents 30 (2007) 345-351
31. McGee L., Wang H., Wasas A., Huebener H., Chen M., and Klugman K.P. Prevalence of serotypes and molecular epidemiology of Streptococcus pneumoniae strains isolated from children in Beijing, China: identification of two novel multiply-resistant clones. Microb Drug Resist 7 (2001) 55-63
32. Shin J.H., Jung H.J., Kim H.R., Jeong J., Jeong S.H., Kim S., et al. Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea. Antimicrob Agents Chemother 51 (2007) 2625-2627
33. Wang M., Zhang Y., Zhu D., and Wang F. Prevalence and phenotypes of erythromycin-resistant Streptococcus pneumoniae in Shanghai, China. Diagn Microbiol Infect Dis 39 (2001) 187-189
34. Farrell D.J., File T.M., and Jenkins S.G. Prevalence and antibacterial susceptibility of mef(A)-positive macrolide-resistant Streptococcus pneumoniae over 4 years (2000 to 2004) of the PROTEKT US Study. J Clin Microbiol 45 (2007) 290-293
35. Wierzbowski A.K., Nichol K., Laing N., Hisanaga T., Nikulin A., Karlowsky J.A., et al. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998-2004). J Antimicrob Chemother 60 (2007) 733-740
36. Yang F., Zhang Y., and McGee L. Resistance of Streptococcus pneumoniae isolated from patients with respiratory tract infections. Chin J Infect Chemother 1 (2001) 13-16
37. Stephens D.S., Zughaier S.M., Whitney C.G., Baughman W.S., Barker L., Gay K., et al. Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet 365 (2005) 855-863
38. Talbot T.R., Poehling K.A., Hartert T.V., Arbogast P.G., Halasa N.B., Mitchel W., et al. Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 39 (2004) 641-648
39. Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., Lynfield R., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348 (2003) 1737-1746
40. Zhao G.M., Black S., Shinefield H., Wang C.Q., Zhang Y.H., Lin Y.Z., et al. Serotype distribution and antimicrobial resistance patterns in Streptococcus pneumoniae isolates from hospitalized pediatric patients with respiratory infections in Shanghai, China. Pediatr Infect Dis J 22 (2003) 739-742